Mucositis
- 2021 CPG Update – Clinical practice guideline for the prevention of oral and oro-pharyngeal mucositis in pediatric cancer and hematopoietic stem cell transplant patients (open access at European Journal of Cancer)
- Endorsed by the Children’s Oncology Group (COG)
- Archived 2015 CPG – Guideline for the prevention of oral and oropharyngeal mucositis in children receiving treatment for cancer or undergoing haematopoietic stem cell transplantation (open access at BMJ Supportive and Palliative Care)
- Endorsed by the Children’s Oncology Group (COG)
If you have any questions about any of the POGO guidelines, our development processes or guidelines under development, please email:
Paula Robinson, MD, MSc
Senior Manager, Supportive Care and Guidelines
Related Articles
Bruce Power and supplier partners donate $100,000 to Pediatric Oncology Group of Ontario
Originally published on the Bruce Power website, September 25, 2024
Antibacterial ProphylaxisAntifungal ProphylaxisChemotherapy-Induced Nausea & VomitingAcute delayed Phase CINVAnticipatory CINVBreakthrough & Refractory CINVEmetogenicity ClassificationAcute & Delayed Phase CINVChronic Pain*Clostridium Difficile InfectionFatigueFertility Preservation*MucositisOtotoxicityFever and NeutropeniaPlatelet Transfusion*Venous Thromboembolism*
Care Pathways
YOU can be a champion for kids with cancer!
With your help, we will ensure that kids and youth with cancer, their families and survivors of childhood cancer have equitable access to the best care for the best possible outcomes.